Skip to content
  • Sunday, 26 July 2026
  • 2:50 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Pharmaceutical R&D

Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation

Teuku Ryan Jul 25, 2026 0

Sanofi has announced a significant strategic decision to halt the development and forgo filing for approval of its immunology therapy,…

Read More
Data Science & Bioinformatics

Developer Chronicles Journey of Building Bespoke AI Assistant, Citing Enhanced Productivity and Data Sovereignty

Evan Lee Salim Jun 17, 2026 0

The burgeoning landscape of artificial intelligence continues to reshape professional workflows, but for one software engineer, the generic offerings fell…

Read More
Laboratory Automation & Robotics

FDA Commissioner Marty Makary Resigns Amid Pressure from Administration, Citing Policy Conflicts and Agency Instability

Lana Keisha Jun 3, 2026 0

Marty Makary resigned on Tuesday as commissioner of the Food and Drug Administration, effective immediately, amidst a period of intense…

Read More
Pharmaceutical R&D

Wes Streeting Resigns as UK Health Secretary Citing Loss of Faith in Labour Leadership Following Local Election Debacle

Teuku Ryan May 15, 2026 0

The political landscape of the United Kingdom has been significantly reshaped by the dramatic resignation of Wes Streeting, the UK…

Read More
Laboratory Automation & Robotics

FDA Rejects Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study Flaws Amidst Broader Policy Shifts

Lana Keisha Apr 6, 2026 0

Moderna, a leading biotechnology company, announced on Tuesday that the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation…

Read More
Laboratory Automation & Robotics

FDA Refuses to Review Moderna’s mRNA Flu Vaccine Application, Citing Comparator Study Design

Lana Keisha Mar 28, 2026 0

Washington D.C. – Moderna, a leading biotechnology company, has announced that the U.S. Food and Drug Administration (FDA) has issued…

Read More
Biocytogen and Sihuan Pharmaceutical Forge Strategic Alliance to Accelerate Advanced Therapies, Including Novel Weight Loss TreatmentsScience News: A Century of Empowering Public Understanding of Science, Medicine, and TechnologyBreast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.Crossword: Traveling Light
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ